202 related articles for article (PubMed ID: 11831441)
21. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
[TBL] [Abstract][Full Text] [Related]
22. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
23. Mapping of myeloperoxidase epitopes recognized by MPO-ANCA using human-mouse MPO chimers.
Erdbrügger U; Hellmark T; Bunch DO; Alcorta DA; Jennette JC; Falk RJ; Nachman PH
Kidney Int; 2006 May; 69(10):1799-805. PubMed ID: 16557221
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil Gelatinase-Associated Lipocalin Protects from ANCA-Induced GN by Inhibiting T
Schreiber A; Rousselle A; Klocke J; Bachmann S; Popovic S; Bontscho J; Schmidt-Ott KM; Siffrin V; Jerke U; Ashraf MI; Panzer U; Kettritz R
J Am Soc Nephrol; 2020 Jul; 31(7):1569-1584. PubMed ID: 32487561
[TBL] [Abstract][Full Text] [Related]
25. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection.
Villalta D; Tonutti E; Tampoia M; Bizzaro N; Papisch W; Tozzoli R; Stella S
Clin Chem Lab Med; 2004; 42(10):1161-7. PubMed ID: 15552276
[TBL] [Abstract][Full Text] [Related]
26. Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis.
Yoshida M; Sasaki M; Nakabayashi I; Akashi M; Tomiyasu T; Yoshikawa N; Kojima T; Ohno N; Yamada M
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S28-32. PubMed ID: 19646343
[TBL] [Abstract][Full Text] [Related]
27. Antineutrophil cytoplasmic autoantibodies and pathophysiology: new insights from animal models.
Huugen D; Tervaert JW; Heeringa P
Curr Opin Rheumatol; 2004 Jan; 16(1):4-8. PubMed ID: 14673382
[TBL] [Abstract][Full Text] [Related]
28. Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule.
Ye H; Zhao MH; Gao Y; Guo XH; Wang HY
Clin Exp Immunol; 2004 Oct; 138(1):179-82. PubMed ID: 15373922
[TBL] [Abstract][Full Text] [Related]
29. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
Reynolds WF; Stegeman CA; Tervaert JW
Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
[TBL] [Abstract][Full Text] [Related]
30. Association Between Reappearance of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Subgroup Analysis of Nationwide Prospective Cohort Studies.
Watanabe H; Sada KE; Matsumoto Y; Harigai M; Amano K; Dobashi H; Fujimoto S; Usui J; Yamagata K; Atsumi T; Banno S; Sugihara T; Arimura Y; Matsuo S; Makino H;
Arthritis Rheumatol; 2018 Oct; 70(10):1626-1633. PubMed ID: 29790303
[TBL] [Abstract][Full Text] [Related]
31. Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides.
Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Shoenfeld Y
Curr Rheumatol Rep; 2006 Aug; 8(4):292-8. PubMed ID: 16839508
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditions.
Locke IC; Leaker B; Cambridge G
Clin Exp Immunol; 1999 Feb; 115(2):369-76. PubMed ID: 9933467
[TBL] [Abstract][Full Text] [Related]
34. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
[TBL] [Abstract][Full Text] [Related]
35. Clinical features of patients with anti-neutrophil cytoplasmic autoantibodies targeting native myeloperoxidase antigen.
Yamanishi Y; Ito-Ihara T; Nagao T; Uno K; Kobayashi S; Muso E; Shane PY; Firestein GS; Hashimoto H; Okazaki T; Suzuki K
Mod Rheumatol; 2013 Sep; 23(5):963-71. PubMed ID: 23085883
[TBL] [Abstract][Full Text] [Related]
36. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
37. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
[TBL] [Abstract][Full Text] [Related]
38. Kinin B1 Receptor Is Important in the Pathogenesis of Myeloperoxidase-Specific ANCA GN.
Hu P; Su H; Xiao H; Gou SJ; Herrera CA; Alba MA; Kakoki M; Falk RJ; Jennette JC
J Am Soc Nephrol; 2020 Feb; 31(2):297-307. PubMed ID: 31772138
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
40. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
Guo XH; Zhao MH; Gao Y; Wang SF; Gao Y
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):932-5. PubMed ID: 12899790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
